Adeno-associated Virus as a Mammalian DNA Vector.
In the nearly five decades since its accidental discovery, adeno-associated virus (AAV) has emerged as a highly versatile vector system for both research and clinical applications. A broad range of natural serotypes, as well as an increasing number of capsid variants, has combined to produce a repertoire of vectors with different tissue tropisms, immunogenic profiles and transduction efficiencies. The story of AAV is one of continued progress and surprising discoveries in a viral system that, at first glance, is deceptively simple. This apparent simplicity has enabled the advancement of AAV into the clinic, where despite some challenges it has provided hope for patients and a promising new tool for physicians. Although a great deal of work remains to be done, both in studying the basic biology of AAV and in optimizing its clinical application, AAV vectors are currently the safest and most efficient platform for gene transfer in mammalian cells.
Gene Therapy Center, Department of Pharmacology, University of North Carolina, Chapel Hill, NC.
Max
M
Salganik
Gene Therapy Center, Department of Pharmacology, University of North Carolina, Chapel Hill, NC.
Matthew L
ML
Hirsch
Gene Therapy Center, Department of Pharmacology, University of North Carolina, Chapel Hill, NC.
Richard Jude
RJ
Samulski
D000818:Animals; D000229:Dependovirus / Q000235:genetics* / Q000378:metabolism; D018014:Gene Transfer Techniques / Q000295:instrumentation; D015316:Genetic Therapy / Q000295:instrumentation; D005822:Genetic Vectors / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008322:Mammals / Q000235:genetics*